However, further analyses indicated that higher baseline rsFC between the MTL and the PMC might be detrimental with respect to cognitive change for APOE4 carriers, but not for APOE4 non-carriers, in our sample without evidence of AD pathology. The gene discussed is APOE; the disease is Alzheimer disease.